Advances in Rheumatology

Papers
(The H4-Index of Advances in Rheumatology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil28
Could ultrasound and muscle elastography be associated with clinical assessment, laboratory and nailfold capillaroscopy in juvenile dermatomyositis patients?27
Assessment of gait in patients with fibromyalgia during motor and cognitive dual task walking: a cross-sectional study26
Takayasu’s arteritis associated with tuberculosis: a retrospective study25
Efficacy of two doses of intra-articular ozone therapy for pain and functional mobility in knee osteoarthritis: a double-blind randomized trial22
Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study19
Flow cytometry evaluation of CD14/CD16 monocyte subpopulations in systemic sclerosis patients: a cross sectional controlled study17
Effect of curcumin on the expression of NOD2 receptor and pro-inflammatory cytokines in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA) patients17
Official Position of the Brazilian Association of Bone Assessment and Metabolism (ABRASSO) on the evaluation of body composition by densitometry—part II (clinical aspects): interpretation, reporting, 16
The effect of rehabilitation protocol using mobile health in overweight and obese patients with knee osteoarthritis: a clinical trial15
Sacroiliac and spine imaging in spondyloarthritis: Does phenotype or sex matter?14
A brazilian nationwide multicenter study on deficiency of deaminase-2 (DADA2)14
“In Memoriam” – Rosa Maria Rodrigues Pereira (1958 – 2022)14
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis13
Role of type 2 ryanodine receptor stabilisation in autoimmune cell modulation13
COVID-19 vaccination of patients with chronic immune-mediated inflammatory disease13
0.076406955718994